Documentary explores dementia using decayed film
The makers of a new documentary have used decayed 16mm film to represent "what dementia might feel like inside the mind". The ...
Organically Human on MSN3h
Internet Use a Modifiable Dementia Risk Factor?
If you have older family members looking to brush up on their social media skills, this could be more than a nice gesture. A ...
Nottinghamshire Live on MSN8h
Millions of Brits at risk of dementia due to common sleep disorder - the red flags to look out for
A common sleep disorder that affects millions of Brits can raise your risk of dementia, according to health experts ...
Medscape10m
Leqembi Okayed for Subset of Early Alzheimer’s Patients
The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...
Hosted on MSN16h
Early signs of dementia that may be seen before memory loss
a common brain disorder causing damage to human brain cells. Dementia in recent times has become very common as damage to ...
Ottawa Citizen on MSN7hOpinion
Frank: Here's why we should prioritize Alzheimer's treatment
We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...
PharmiWeb6h
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
Eisai Europe Ltd. and Biogen Inc. announced today that a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
JCN Newswire8h
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
TOKYO, Nov 15, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Japan Ltd announced today that a TV commercial will be ...
GlobalData on MSN20h
EMA rethinks stance, committee now recommends Leqembi for Alzheimer’s disease
Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.
cambridgeindependent10h
Glaucoma drug shows promise in fight against neurodegenerative diseases, say University of Cambridge experts
A drug used to treat glaucoma holds promise in the fight against various forms of dementia, according to University of ...
EMA recommends Leqembi for treatment of early Alzheimer’s disease
After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...
‘The Unicorn' at UNTHSC is a gamechanger, say Alzheimer's researchers
Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...